Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.
Journal: Haematologica
Published: December 09, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.
Journal: Science advances
Published: December 05, 2025
Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
Journal: American journal of hematology
Published: March 14, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.
Journal: Leukemia
Published: October 08, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.
Journal: bioRxiv : the preprint server for biology
Published: June 25, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Journal: Blood
Published: June 17, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 15, 2024
Last Updated: 09/26/2026